No association between DLST gene and Alzheimer's disease or Wernicke-Korsakoff syndrome.
Among many candidate genes for the genetically heterogeneous Alzheimer's disease (AD), only apolipoprotein E (ApoE) has been confirmed. Another candidate is the dihydrolipoyl succinyltransferase (DLST) gene, one of three components of thiamine-dependent mitochondrial alpha-ketoglutarate dehydrogenase complex (KGDHC), because KGDHC activity is reported reduced in AD patients. Also characterized by reduced KGDHC activity is another neuropsychiatric disease, Wernicke-Korsakoff syndrome (WKS), which results from thiamine deficiency. Examination of specific DLST gene polymorphism in 247 Japanese AD patients, 53 alcoholic WKS patients, and 368 nondemented Japanese control subjects revealed no significant differences in DLST genotypes and failed to replicate the findings of earlier studies indicating an association between DLST gene polymorphism and AD.
Matsushita
S
S
Department of Clinical Research, National Institute on Alcoholism, Kurihama National Hospital, Yokosuka, Kanagawa, Japan.
Arai
H
H
Yuzuriha
T
T
Kato
M
M
Matsui
T
T
Urakami
K
K
Higuchi
S
S
D000217:Acyltransferases / Q000235:genetics*; D000368:Aged; D000437:Alcoholism / Q000235:genetics; D000544:Alzheimer Disease / Q000235:genetics*; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000235:genetics; D003072:Cognition Disorders / Q000235:genetics; D005260:Female; D005838:Genotype; D006801:Humans; D007564:Japan; D020915:Korsakoff Syndrome / Q000235:genetics*; D008297:Male; D012150:Polymorphism, Restriction Fragment Length
D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D000217:Acyltransferases; C021515:dihydrolipoamide succinyltransferase